24 May 2022
Online
Africa/Accra timezone

Implementing Multi-Factor Authentication on Shibboleth Identity Provider (IdP) using Microsoft 365: Case of NIH Collaboration in Mali and Uganda

24 May 2022, 13:20
20m
https://wacren.zoom.us/j/69303914097 (Online)

https://wacren.zoom.us/j/69303914097

Online

Presentation Infrastructure

Speaker

Mr Ivan Frank Nsimbi (Research Data and Communication Technologies)

Description

The Research and Education FEDerations group (REFEDS) Multi-Factor Authentication (MFA) Profile defines a standard signal Service Providers (SPs) may send to Identity Providers (IdPs) requesting the use of MFA during federated authentication flows. The IdP includes the corresponding signal in its response to indicate that MFA has occurred. The Profile also defines the minimum criteria a second authentication factor must meet for the IdP to claim successful MFA.
The National Institutes of Health (NIH) announced in June 2021 that it would require MFA for access to some of its resources. As part of the rollout, NIH would require trusted IdPs to support the REFEDS MFA Profile. As more SPs in the Research and Education community continue to require MFA for federated access, IdPs must implement the MFA profile soon.
This case study will describe the technical implementation details and challenges faced while enabling the REFEDS MFA profile on the Shibboleth IdPs for the NIH International Centers of Excellence in Research (ICERs) in Uganda and Mali using Microsoft 365 for issuing MFA tokens.

Primary authors

Mr Ivan Frank Nsimbi (Research Data and Communication Technologies) Mr Lloyd Ssentongo (NIH Uganda ICER / RDCT) Mr Matthew Economou (Office of Cyber Infrastructure and Computational Biology National Institute of Allergy and Infectious Diseases, NIH) Mr Sidy Soumare (NIH Mali ICER / RDCT) Mr Keith Wessel (University of Illinois at Urbana-Champaign) Mr Chris Phillips (CANARIE) Mr Christopher Whalen (Office of Cyber Infrastructure and Computational Biology National Institute of Allergy and Infectious Diseases, NIH) Mr Michael Tartakovsky (Office of Cyber Infrastructure and Computational Biology National Institute of Allergy and Infectious Diseases, NIH)

Presentation materials